
A Linker Protein Gene Therapy Approach For LAMA2-CMD
Dr. Yurchenco (NJ, USA) and Dr. Rüegg (Basel, Switzerland) are collaborating with Santhera Pharmaceuticals to develop an emerging gene therapy…
Dr. Yurchenco (NJ, USA) and Dr. Rüegg (Basel, Switzerland) are collaborating with Santhera Pharmaceuticals to develop an emerging gene therapy…
The Generate Your Muscle (GYM) project was recently set up with the aim of developing and commercialising affordable stem cell…
After being diagnosed with LAMA2-CMD at 39 years old, Cindy experienced 3 seizures, the last being generalised. This prompted brain…
Dr. Dwi Kemaladewi is playing a a key role in developing a novel therapeutic approach that has opened new treatment…
Steven Axon is the CEO of Prothelia, a biopharmaceutical company based in Massachusetts, USA, committed to developing a promising new…
Professor Bert Smeets is involved in a number of investigations looking into a muscle stem cell treatment strategy to treat…